SCHEMBL2814048

SCHEMBL2814048

c1ccc(CC2CCN(c3nc4c5c(n3)N(Cc3ccccc3)CCC5NN4)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
CCR3 P51677 1/20 0.41
MAPT P10636 8/20 0.40
LMNA P02545 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HTT P42858 5/20 0.39
NPC1 O15118 1/20 0.39
STAT3 P40763 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 8/20 0.39
NPSR1 Q6W5P4 2/20 0.39
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HPGD P15428 2/20 0.37
MAPK1 P28482 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812041 0.89 CASP1 (0.40) TSHRHTTL3MBTL1ALDH1A1NPSR1
SCHEMBL2812365 0.88 DRD4 (0.39) TSHRMAPTSMN1; SMN2HTTALDH1A1
SCHEMBL2809502 0.87 HTR6 (0.41) HTTNPC1ALDH1A1KDM4E
SCHEMBL2809650 0.87 ALDH1A1 (0.40) TSHRMAPTLMNAALDH1A1MEN1
SCHEMBL2810802 0.83 CASP1 (0.43) TSHRMAPTLMNAHTTALDH1A1
SCHEMBL2810547 0.83 KDM4E (0.43) TSHRMAPTLMNASMN1; SMN2HTT
SCHEMBL2809611 0.83 EHMT2 (0.42) TSHRMAPTLMNASMN1; SMN2HTT
SCHEMBL2811977 0.82 HCAR2 (0.36) TSHRMAPTLMNAHTTNPSR1
SCHEMBL2809662 0.82 PIK3R1 (0.39) TSHRLMNAL3MBTL1ALDH1A1MEN1
SCHEMBL2813990 0.82 KDM4E (0.38) TSHRMAPTSMN1; SMN2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 TSHR 3555/4885CCR3 1012/4885MAPT 2947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.